Chr rearrangement(11)(q23)

News alerts, weekly reports and conference planners

Chr rearrangement(11)(q23)	Acute Myelogenous Leukemia	Chr rearrangement(11)(q23)	Acute Myelogenous Leukemia	cytarabine/daunorubicin liposomal formulation Resistant: C3 – Early Trials cytarabine / daunorubicin liposomal formulation Resistant : C3	cytarabine/daunorubicin liposomal formulation Resistant: C3 – Early Trials cytarabine / daunorubicin liposomal formulation Resistant : C3
Chr rearrangement(11)(q23)	Acute Myelogenous Leukemia	Chr rearrangement(11)(q23)	Acute Myelogenous Leukemia	cytarabine Resistant: C3 – Early Trials cytarabine Resistant : C3	cytarabine Resistant: C3 – Early Trials cytarabine Resistant : C3

Associations